Real-world data from observational, noninterventional, prospective, multicenter studies of FVIII prophylaxis in all severity forms of hemophilia A demonstrate that only 34% to 56% of people with hemophilia can achieve a state of no bleeding with FVIII prophylaxis [34]. This evidence concerns the gene F8 and hemophilia.